German Stem Cell Club - Coming up

06 November 202516:15 - 17:45
 Zoom link
Flyer
External Speaker: Agnete Kirkeby (University of Copenhagen and Novo Nordisk Foundation reNEW, Denmark)
Title: Pluripotent stem cell therapies in the clinic

Local Speaker: Claudia Crocini (Charité - Universitätsmedizin Berlin & DZHK, Berlin)
Title: Impact of titin N2B deletion on the nucleus of hiPSC-derived cardiomyocytes​

Upcoming GSCC:
04 Dec. 2025
- Annika Hausmann (ETH Zurich Switzerland)
 

All about the 13th GSCN Conference

Direct Link to the GSCN Conference website: gscn-conferences.org/gscn-conference-2025

A superb meeting: The 13th GSCN Conference (15 until 17 Oct. 2025) was a scientific highlight and an outstanding networking event: With the high ranked key note speakers Viviane Tabar (New York City, USA), Timm Schroeder (Basel, Switzerland), Jacob Hanna (Rehovot, Israel), Wolfram-Hubertus Zimmermann (Göttingen, Germany),  Hongkui Deng (Beijing, China), and  Maria-Elena Torres-Padilla (Munich, Germany), three GSCN Awardees, 54 talks, three symposia, two poster sessions, a new record with 450 participants, two networking events, a non-PI Meeting, a computational workshop - and a great atmosphere.  Thank you all for being part in the conference and i nout network - and see you next year in Berlin (9 - 11 Sept. 2026). 

GSCN Awards 2025

The "GSCN 2025 Young Investigator Award" goes to  Aydan Bulut-Karslıoğlu of the Max Planck Institute of Molecular Genetics in Berlin.
The GSCN 2025 Hilde Mangold Award goes to Michaela Frye from the German Cancer Research Center in Heidelberg.
The GSCN Publication of the Year Award 2025 goes to Bryce Lim, Aryan Kamal, … , Judith Zaugg and Moritz Mall. They receive the "GSCN 2025 Publication of the Year Award" for their joint publication "Active repression of cell fate plasticity by PROX1 safeguards hepatocyte identity and prevents liver tumorigenesis” in the journal Nature Genetics 57, 668–679 (2025).

Find the GSCN press release Molecular Insights into Early Development and Cancer Formation  here  
Finden Sie die GSCN Pressemitteilung Molekulare Einblicke in frühe Entwicklung und Tumorentstehung  hier
Please find all information  here.

Brandnew online: GSCN Annual Magazine 2024/25

Stem cells: Aging & Cancer

Content: 

12th GSCN Conference Report 2024

  • When stem cells age: Ways to rejuvenate
  • Stem cells and blood cancer: Order in chaos
  • Stem cells and tumors: Strategies against the master of metarmophosis
  • GCT: Autoimmune disease succesfully treated with CAR-T cells
  • GCT: Master plan to bring innovations to patients faster
  • BIH: BeCAT - Interview with Annette Künkele-Langer
  • Portrait of an institute: MHH

Read it online  here (with download link).
Read the German version  here (with download link).

Members
Active Bioscience
Berlin-Brandenburger Center for Regenerative Therapies (BCRT)
AMSBIO
Center for Regenerative Therapies Dresden (CRTD)
BioLamina AB
CRU5024
Biomerieux
German Cancer Research Center (DKFZ)
bio-techne
Fraunhofer IBMT
bit.bio
Fraunhofer Institute for Production Technology (IPT)
BlueRock Tx
Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP)
Catalent
HI-STEM - Heidelberg Institute for Stem Cell Technology and experimental Medicine
Eppendorf AG
Helmholtz Zentrum München (HMGU)
Green Elephant
Institute of Reconstructive Neurobiology
iotaSciences
ISAR Bioscience
Miltenyi Biotec
Leibniz IUF Dortmund
OLS - OMNI Life Science
Leibniz Institute on Aging/Fritz Lipmann Institute (FLI)
PELOBiotech GmbH
Leibniz Institute for Zoo and Wildlife Research
Proteintech Group
Max Delbrück Center for Molecular Medicine Berlin-Buch (MDC)
Sartorius
Max Planck Institute for Heart and Lung Research
Stemcell Technologies
Max-Planck-Institute for Molecular Genetics
Takara Bio SAS
Rebirth Cluster of Excellence
Thermo Fisher Scientific - LSG
Tron gGmbH
TreeFrog
Tissue Engineering and Regenerative Medicine
Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie
Send an e-mail
GSCN Humhub

20 March is UniStem Day 2026.
 All information here

Funding Opportunities & Programs
Funding of translational projects for therapies with gene- and cell-based products and associated diagnostics

The aim of this funding program is to support the translation of research results in the field of GCT and thus contribute to the implementation of a National Strategy for Gene- and Cell-based Therapies in Germany.

The DLR Projekträger (Project Managment Agency at German Aerospace Center) has announced the  funding opportunities (DE) on 15 July 2024.
For further information, please refer to the ➚ announcement (DE) and the publication National Strategy for Gene- and Cell-based Therapies in Germany from the BIH.

From the Press

Update of ISSCR Guidelines for Stem Cell Research and Clinical Translation in the section the section on stem cell–based embryo models.
Source: ISSCR.org, 14.08.2025 

How immune cells communicate to fight infections and cancer (GSCN)
Source: bihealth.org, 06.08.2025

All-in-one model reconstructs complex liver architecture (GSCN)
Source: mpi-cbg.de, 29.05.2025

The Return of the Dire Wolf
Angeblich Schattenwolf mit Gentechnik erschaffen: Experten sind skeptisch 
(GSCN)
Source: Time, 07.04.2025; WDR - YouTube, 09.04.2025

Neural stem cells outside the brain​ (GSCN)
Source: Max-Planck-Gesellschaft, 10.04.2025

Pluripotency factor Oct4 gets a makeover (GSCN)
Source: The Scientist, 12.03.2025

Guardian molecule keeps cells on track – new perspectives for the treatment of liver cancer (GSCN)
Source: DKFZ.de, 13.02.2025

Miniature hearts for research (GSCN)
Source: MHH.de, 10.12.2024

Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update
Source: Cell Stem Cell, 02.01.2025

In Focus: Plant genome editing. A current stocktaking of the Working Group Gene Technology Report
Source: gentechnologiebericht.de, 9.12.2024

Carsten Marr receives Eugen Münch Award (GSCN)
Source: Helmholtz-Munich-de. 22.11.2024

Diabetes switch in DNA (GSCN)
Source: Uni Ulm, 31.10.2024

 News Archive

students at laboratory
students at auditorium